Presented by Coalition to Strengthen America’s Healthcare {beacon} Healthcare Healthcare The Big Story RFK Jr. advances peptide push The Food and Drug Administration (FDA) this week submitted a peptide “interim access policy” to the White House for review, according to a government filing, which would reportedly allow compounding pharmacies to temporarily produce and sell previously restricted…
FDA advances peptide push to White House
Originally reported by The Hill. Read the full story at the original source.
Related Articles
Judge Refuses to Reverse Penalties Against Crypto Firm With Ties to Trump Family
The ruling denied a bid by Gemini Trust and the C.F.T.C. to nullify a settlement that required the company to pay $5 mil...
Noem out of Shield of America’s role, State Department confirms
Former Homeland Security Secretary Kristi Noem is no longer serving as the Trump administration’s special envoy to the &...
Pentagon’s school system director stepping down
Welcome to The Hill’s Defense & NatSec newsletter {beacon} Defense &National Security Defense &Nati...
Trump Cancels Planned Execution Livestream of Nidal Hasan, Fort Hood Shooter
The president said only immediate families of the victims of the mass shooting in 2009 would witness the execution of Ma...